When was the last time you heard a medical device company say the first market it’s pursuing is Central America? But that’s the plan for Biomeme’s Smartphone-enabled lab. Its mobile qPCR thermocycler is designed to amplify trace amounts of DNA to identify particular strains of pathogens by their DNA signature. It’s also designed to do real-time disease tracking at the point of care.